Werkgroep Cardiologische centra Nederland

RESTORE-1 (Recruiting)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Flecainide Acetate Inhalation Solution for Cardioversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm
Medicine
FlecIH-103
Population
Arrhythmia
Phase
III
Starting year
2021

Director of Study

S. Eijsbouts (Cardioloog)
Veldhoven, Máxima Medisch Centrum